242
Views
5
CrossRef citations to date
0
Altmetric
INVITED EDITORIALS

Estrogen as a new option for prevention and treatment of breast cancer – does this need a ‘time gap’?

&
Pages 444-447 | Received 02 Apr 2015, Accepted 14 Apr 2015, Published online: 11 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

X. Ruan & A. O. Mueck. (2023) The WHO claims estrogens are ‘carcinogenic’: is this true?. Climacteric 26:3, pages 263-270.
Read now

Articles from other publishers (2)

Robert P. Kauffman, Christina Young & V. Daniel Castracane. (2021) Perils of prolonged ovarian suppression and hypoestrogenism in the treatment of breast cancer: Is the risk of treatment worse than the risk of recurrence?. Molecular and Cellular Endocrinology 525, pages 111181.
Crossref
Alfred O. Mueck. (2017) Transdermales Östradiol und ProgesteronTransdermal estradiol and progesterone. Gynäkologische Endokrinologie 15:1, pages 65-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.